Women's Health

 

Women's Health and Osteoporosis Studies That Should Be on Your Radar

November 20, 2020

Over the course of this year there have been some pivotal studies on osteoporosis and women's health. We've published stories based on studies that explore the use of vitamin D and calcium supplementation and bone mineral density. We've featured a few studies that examine the effectiveness of bisphosphonates and the role of anabolic agents to to fight osteoporosis. Learn more about these and other studies in today's slideshow.

Treatment Sequence Matters in Osteoporosis

November 18, 2020

Osteoporosis therapeutic treatments should always be individualized, says Felicia Cosman, M.D., an endocrinologist with Columbia University College of Physicians and Surgeons in New York. Dr. Cosman is the author of a study recently presented at the American College of Rheumatology annual meeting in which she shared results from a study that explored treatment sequences with romosozumab before or after antiresorptive medication.

Individualized Approach Needed for Bisphosphonate Use in Women

October 07, 2020

In women 50 years of age or older, the risk of atypical femur fracture increased with longer bisphosphonate use, Asian ancestry, shorter height, higher weight and glucocorticoid use for one year or more, but this risk rapidly decreased after bisphosphonate discontinuation, according to a study recently published in New England Journal of Medicine.

Bisphosphonate Use Associated with Increased Fracture Risk

September 16, 2020

Bisphosphonate use, especially for more than five years, is associated with an increased risk of atypical femoral fractures, but this risk falls considerably after discontinuation, according to a Nationwide Danish an analysis and review presented on September 13 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which was held virtually.

High-Intensity Activity in Adolescence May Help Prevent Osteoporosis

September 14, 2020

Spending more time in high-intensity physical activity in early life may protect against osteoporosis in later life, and men are more successful at this than women, according to a study recently published in JAMA Network Open.

Calcium and Vitamin D First to Reduce Fracture Risk?

September 14, 2020

Drug therapy appears to be the first-line option for reducing fracture risk in osteoporosis, but it is not always feasible, and increasing calcium, vitamin D and protein intake may be a more practical option.

Q&A: Vitamin D and Bone Mineral Density

September 14, 2020

High-dose vitamin D supplementation compared with standard-dose vitamin D supplementation resulted in a greater loss of volumetric bone mineral density in women but not men, according to study data presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

Q&A: Anabolic Agents for Osteoporosis

September 14, 2020

Three months of treatment with the osteoporosis drug abaloparatide (Tymlos, Radius) has a robust effect on bone formation in postmenopausal women with osteoporosis, according to a study presented on Sept. 12 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which is being held virtually.

Podcast: Are your patients well verse on vitamin D intake?

August 03, 2020

Managing vitamin D levels may not be as straightforward as it would seem. There are factors that should be considered that are not often communicated to patients. In today's edition of Overdrive, the Rheumatology Network podcast, we talk with Dr. Suzanne Jan de Beur of Johns Hopkins University School of Medicine. She serves as director of endocrinology at Johns Hopkins Bayview Medical Center and president-elect of the American Society for Bone and Mineral Research.

20 Key Takeaways From the Rheumatology Pregnancy Guidelines

February 28, 2020

Most women with rheumatic and musculoskeletal diseases will have successful pregnancies with the aid of medical planning, treatment and monitoring. These can be high risk pregnancies for both mother and child. The American College of Rheumatology recently issued treatment guidelines for the management of reproductive health in patients with rheumatic or musculoskeletal disease. Here are takeaways from the guidelines.

Treatment Guidelines Issued for Reproductive Health in Rheumatic and Musculoskeletal Diseases

February 25, 2020

New this week: The American College of Rheumatology has issued treatment guidelines for the management of reproductive health in rheumatic and musculoskeletal diseases. They include 12 ungraded good practice statements and 131 graded recommendations for all female patients considering becoming pregnant.

Probiotics Protect Against Lumbar Spine Bone Loss in Early Menopause

January 28, 2020

Probiotic supplementation using a mix of three Lactobacillus strains naturally occurring in the human gut microbiota protects against lumbar spine bone loss in healthy, early postmenopausal women, say researchers recently writing in The Lancet Rheumatology.